Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer.

REVEAL GENOMICS ®, a pioneering Barcelona-based biotech company dedicated to advancing precision oncology, is proud to announce the publication of a groundbreaking study demonstrating the clinical ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...

Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...

Jaime King no longer has physical custody of the two sons she shares with ex-husband Kyle Newman. Court documents revealed ...

Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from ...

Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation ...

Vepdegestrant is a novel proteolysis targeting chimera protein degrader designed to target and degrade the estrogen receptor.

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...